Johnson & Johnson Wins FDA Approval For Expanded Brain Bleed Treatment

source:

[1] Johnson & Johnson Receives FDA Approval for TRUFILL n-BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma (https://finance.yahoo.com/news/johnson-johnso ...)

Johnson & Johnson Wins FDA Approval For Expanded Brain Bleed Treatment

Related News

Babcock & Wilcox Secures $40M Refinery Contract

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes